Said differently, to identify the payment amount benchmark period for the purpose of calculating the benchmark period manufacturer price for a Part D rebatable drug first approved or licensed on or before October 1, 2021, CMS would first look to the period from January 1, 2021, to September 30, 2021 and if no AMP was reported to the MDRP for that 3-quarter period, CMS would then identify the payment amount benchmark period as the first calendar year no earlier than calendar year 2021 in which such drug has at least 1 quarter of AMP reported
Our results provide compelling evidence for the role of Miro1 in airway epithelial cells by mediating inflammatory responses associated with HDM exposure and build upon our previous studies showing the importance of mitochondrial DRP1 to this process (54, 55) that where next explored in this study
Dark, dirty, unapologetic
I don't think I've ever called a tobacco or a cigar fun, but really, that's what this is
The attorneys general also challenged certain advertising campaigns, such as the Marlboro Man and Joe Camel
Kool-Aid also launched partnerships with toy brands like Hot Wheels and Barbie
